Evaluation reveals neurodegeneration and altered magnetization transfer ratio in patients with Parkinson's, suggesting ST-MRF may be a useful biomarker.
Abstract Parkinson’s disease (PD) is marked by progressive neurodegeneration in the substantia nigra (SN). This study evaluated deep-learning saturation transfer magnetic resonance fingerprinting (ST-MRF) to quantify molecular and microstructural changes in PD. We examined 23 patients with PD and 22 matched healthy controls using multimodal imaging, including ST-MRF. ST-MRF detected significant molecular and microstructural alterations in the SN of PwPD compared to HCs, including increases in magnetization transfer ratio at 3.5 ppm (MTR (3.5ppm, 1.5 µT); 0.61 ± 0.02 vs. 0.60 ± 0.02, p = 0.014), MTR (-3.5ppm, 1.5 µT); 0.61 ± 0.02 vs. 0.59 ± 0.02, p = 0.008)), and decreases in T2w (51.9 ± 3.4 ms vs. 54.5 ± 1.3 ms, p = 0.005), suggesting disrupted protein homeostasis, axonal loss, and iron accumulation. ST-MRF provides multi-parametric insights into PD-related pathology and may serve as a quantitative biomarker for future clinical trials. Further validation in larger, longitudinal cohorts is warranted.
No takes yet. Share an insight, caveat, or question.
Prasuhn et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: